Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001447923 | SCV001651003 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2025-01-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002432246 | SCV002729444 | likely benign | Cardiovascular phenotype | 2022-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001447923 | SCV002794896 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2021-08-09 | criteria provided, single submitter | clinical testing |